Teen Marijuana Check-Up

Sponsor
Denise Walker (Other)
Overall Status
Completed
CT.gov ID
NCT01109563
Collaborator
Virginia Polytechnic Institute and State University (Other), National Institute on Drug Abuse (NIDA) (NIH)
252
2
42.1

Study Details

Study Description

Brief Summary

This study will test a behavioral intervention tailored for adolescents who smoke marijuana and have concerns about their use. The study's purpose is to determine whether this intervention (two-sessions of motivational enhancement intervention followed by 12 months of optional skills training) will be more effective in reducing the use of this drug if augmented by three periodic motivational enhancement treatment check-in sessions as compared to three periodic computer-based check-in sessions.

HYPOTHESES: (1) Participants in the motivational enhancement treatment check-ins (MCI) condition will reduce their use of marijuana more than participants in the computer based (Comp) condition and report fewer negative consequences. These differences are expected to be greater at later follow-ups (i.e, 9, 12, and 15 months) after repeated check-ins exert a cumulative effect. (2)Engagement in CBT sessions will be greater for those in the MCI condition and will partially mediate the effect on marijuana related outcome indices. (3) The MCI intervention will lead to increased self-efficacy, and decreased normative perceptions of marijuana use by other teens that will also partially mediate the effect of the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Marijuana Check-Ins
Phase 3

Detailed Description

The goal of this trial is to evaluate the efficacy of an enhanced Teen Marijuana Check-Up protocol to reach and intervene with non-treatment seeking adolescents who use marijuana heavily. Two hundred fifty adolescents who use marijuana heavily will receive a 2-session individual motivational enhancement therapy. All participants will also be offered the opportunity, over a 12-month period, to repeatedly re-initiate marijuana counseling. Participants will be randomly assigned to receive one of two types of periodic follow-up contacts: Motivational interviewing-based Marijuana Check-Ins (MCI) or Computer Based Control (Comp) sessions.

All participants will be reassessed at the 6, 9, 12, and 15-month anniversaries of enrollment. Following their initial motivational enhancement therapy, the 125 experimental condition participants will additionally have a motivational enhancement treatment "check-in" session with their counselor at the 4, 7, and 10-month anniversaries of enrollment intended to reinforce the maintenance of treatment gains and motivate continued success, increase motivation to change for participants who did not meet their marijuana use goals, and/or prompt utilization of cognitive-behavioral treatment (CBT) sessions as needed. The 125 comparison participants will complete a computer based questionnaire at the same time intervals to serve as an attentional control.

Study Design

Study Type:
Interventional
Actual Enrollment :
252 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Reaching and Motivating Change in Teen Marijuana Smokers
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Computer Check-In Control

The Computer Check-In gives the participant contact with the research therapist, an assessment of marijuana use and the current impact of use, and a reminder about optional support sessions.

Behavioral: Marijuana Check-Ins
The MCI, an MET intervention, will include the provision of personalized feedback with a motivational interviewing style. The focus of these sessions will be individualized to participants based on recent marijuana use and related experiences. Feedback given to participants during the MCI session will review progress toward goals as self-reported in percent days abstinent, normative data regarding marijuana use, review of reported consequences of marijuana use, review of abuse and dependence criteria reported, comparison of consequences and abuse and dependence symptoms reported over time, review of the positive outcomes from reductions in use, and review of immediate and long-term life goals and how their marijuana goal will affect these. HEs will offer particular encouragement to take advantage of CBT sessions to participants who feel they currently need treatment.

Experimental: Marijuana Check-Ins

The MCI, a MET intervention, will include the provision of personalized feedback with a motivational interviewing style. The focus of these sessions will be individualized to participants based on recent marijuana use and related experiences. Feedback given to participants during the MCI session will review progress toward goals as self-reported in percent days abstinent, normative data regarding marijuana use, review of reported consequences of marijuana use, review of abuse and dependence criteria reported, comparison of consequences and abuse and dependence symptoms reported over time, review of the positive outcomes from reductions in use, and review of immediate and long-term life goals and how their marijuana goal will affect these. HEs will offer particular encouragement to take advantage of CBT sessions to participants who feel they currently need treatment.

Behavioral: Marijuana Check-Ins
The MCI, an MET intervention, will include the provision of personalized feedback with a motivational interviewing style. The focus of these sessions will be individualized to participants based on recent marijuana use and related experiences. Feedback given to participants during the MCI session will review progress toward goals as self-reported in percent days abstinent, normative data regarding marijuana use, review of reported consequences of marijuana use, review of abuse and dependence criteria reported, comparison of consequences and abuse and dependence symptoms reported over time, review of the positive outcomes from reductions in use, and review of immediate and long-term life goals and how their marijuana goal will affect these. HEs will offer particular encouragement to take advantage of CBT sessions to participants who feel they currently need treatment.

Outcome Measures

Primary Outcome Measures

  1. frequency (number of days) of marijuana use [60 days]

    Global Appraisal of Individual Needs - I (self-report measure)

  2. treatment utilization [90 days]

    Global Appraisal of Individual Needs - I

  3. marijuana abuse/dependence symptoms [60 days]

    Global Appraisal of Individual Needs - I

  4. engagement in cognitive behavioral skills training sessions [90 days]

    Frequency of attendance at optional in-school counseling sessions

Secondary Outcome Measures

  1. self-efficacy [90 days]

    Self-efficacy scale that assesses self-efficacy for avoiding marijuana use

  2. normative perceptions of peer marijuana use [90 days]

    Descriptive perceived norms concerning the frequency of marijuana use by other adolescents of the participant's age

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. age (14-19 years old),

  2. grade level (9th through 11th) and

  3. marijuana use.

Exclusion Criteria:
Individuals will be excluded if:
  1. they are not fluent in English,

  2. they have a thought disorder that precludes full participation,

  3. they refuse to accept randomization to condition,

  4. they are high school seniors.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Denise Walker
  • Virginia Polytechnic Institute and State University
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Denise D Walker, PhD, University of Washington School of Social Work

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Denise Walker, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier:
NCT01109563
Other Study ID Numbers:
  • 37852-G
  • 2R01DA014296-09A1
First Posted:
Apr 23, 2010
Last Update Posted:
Oct 27, 2016
Last Verified:
Oct 1, 2016
Keywords provided by Denise Walker, Principal Investigator, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2016